Boston Scientific (NYSE:BSX) announced that it completed its acquisition of Valencia Technologies. Marlborough, Massachusetts-based Boston Scientific announced an agreement to acquire the urinary incontinence treatment developer in January. The companies did not disclose the financial details of the acquisition. This marks the latest major acquisition for the company’s Urology portfolio, which added Axonics in 2024. Valencia Technologies develops solutions for treating bladder dysfunction. Its FDA-approved eCoin implantable tibial nerve stimulation (ITNS) device treats urge urinary incontinence (UUI), a common symptom of overactive bladder (OAB).
Read the full article: Boston Scientific Completes Valencia Technologies Acquisition //
Source: https://www.massdevice.com/boston-scientific-completes-valencia-technologies-acquisition/